| Financial Year |
March 31 2022 |
| Monetary Funds |
617,014,827.84 |
| Held-for-trading Financial Assets |
499,636,108.55 |
| Notes Receivable |
-- |
| Accounts Receivable |
358,613,485.84 |
| Advances to Suppliers |
31,169,537.77 |
| Other Receivables |
6,231,778.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
702,221,543.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
142,567,699.00 |
| Total Current Assets |
2,357,454,980.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
29,879,986.88 |
| Investment Properties |
-- |
| Fixed Assetes |
400,412,455.50 |
| Under-construction Projects |
140,888,531.41 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
103,162,150.31 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
20,969,545.04 |
| Deferred Income Tax Assets |
46,836,136.87 |
| Other Non-Current Assets |
13,856,321.14 |
| Sub-Total of Non-Current Assets |
827,300,849.35 |
| Total Assets |
3,184,755,829.94 |
| Short-Term Loans |
245,631,670.42 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
551,399,154.51 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
26,714,244.90 |
| Taxes Payable |
18,270,906.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,690,797.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
171,498.34 |
| Other Current Liabilities |
755,334.88 |
| Sub-Total of Current Liabilities |
868,348,586.41 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
755,669.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
33,385,281.81 |
| Total Liabilities |
901,733,868.22 |
| Paid-In Capital(Or Share Stock) |
338,388,800.00 |
| Capital Surplus |
1,606,456,813.40 |
| Surplus Reserve |
33,780,002.63 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
295,036,221.47 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,283,021,961.72 |
| Owner's Equity（Stockholder's Equity） |
2,283,021,961.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,184,755,829.94 |
